Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Testosterone and Alendronate in Hypogonadal Men

This study has suspended participant recruitment.
Sponsor:
Collaborators:
Endo Pharmaceuticals
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Benjamin Leder, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01460654
First received: October 20, 2011
Last updated: November 30, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)